Composition of staphylococcal bi-component toxins determines pathophysiological reactions

Journal of Medical Microbiology

Volumn 46, Issue 6, 1997, Pages 479-485

  Konig B ^a   Prevost G ^b   Konig W ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOLYSIN; LEUKOCIDIN; STAPHYLOCOCCUS TOXIN;

ARTICLE; BASOPHIL; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LYMPHOCYTE; NEUTROPHIL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 0031005547     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-46-6-479     Document Type: Article

References (21)

1. Prevost G, Supersac G, Colin DA et al. The new family of lcucotoxins from Stophylococcus aureus: structural and biological properties. In: Freer JH et al. (eds) Bacterial protein toxins. Zentralbl Bakteriol Suppl 24. Stuttgart, Gustav Fischer Verlag. 1994: 284-293.
2. Supersac G, Prevost G, Piemont Y. Sequencing of leucocidin from Staphylococcus aureus P83 suggests that staphylococcal leucocidins and gamma-hemolysin are members of a single, two-component family of toxins. Infect Immun 1993; 61: 580-587.
3. Guyonnet F, Plommet M. [Gamma hemolysin of Staphylococcus aureus: purification and properties.] Ann Inst Pasteur 1970; 118: 19-33.
4. Cooney J, Kienle Z, Foster TJ, O'Toole PW. The gamma-hemolysin locus of Staphylococcus aureus comprises three linked genes, two of which are identical to the genes for the F and S components of leukocidin. Infect Immun 1993; 61: 768-771.
5. Kamio Y, Rahmann A, Nariya H, Ozawa T, Izaki K. The two staphylococcal bi-component toxins, leukocidin and gamma-hemolysin. share one component in common. FEBS Lett 1993; 321: 15-18.
6. Prevost G. Couppie P, Prevost P et al. Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J Med Microbiol 1995; 42: 237-245.
7. Finck-Barbancon V, Prevost G, Piemont Y. Improved purification of leukocidin from Staphylococcus aureus and toxin distribution among hospital strains. Res Microbiol 1991; 142: 75-85.
8. Criibier B, Prévost G, Couppie P, Finck-Barbancon, P, Grosshans P, Piémont Y. Staphyloeoccus aureus leukocidin: a new virulence factor in cutaneous infections. An epidemiological and experimental study. Dermatology 1993; 185: 175-180.
9. Hensler T, König B, Prévost G, Piémont Y, Köller M, König W. Leukotriene B4-generation and DNA fragmentation induced by leukocidin from Staphylococcus aureus: protective role of granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF on human neutrophils. Infect Immun 1994; 62: 2529-2535.
10. König B, Köller M, Prévost G et al. Activation of human effector cells by different bacterial toxins (leukocidin, alveolysin, erythrogenic toxin A), generation of interleukin-8. Infect Immun 1994; 62: 4831-4837.
11. König B, Prévost G, Piémont Y, König W. Effects of Staphylococcus aureus leucocidins on inflammatory mediator release from human granulocytes. J Infect Dis 1995; 171: 607-613.
12. Prévost G, Cribier B, Couppié P et al. Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect Immun 1995; 63: 4121-4129.
13. Boyum A. Isolation of lymphocytes, granulocytes and macrophages. Scand J Immunol 1976; Suppl 5: 9-15.
14. Bazzoni F, Cassatella MA, Rossi F, Ceska M, Dewald B, Baggiolini M. Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide-1 /interleukin 8. J Exp Med 1991; 173: 771-774.
15. Alouf JE, Knöll H, Köhler W. The family of mitogenic. shock-inducing and superantigenic toxins from staphylococci and streptococci. In: Alouf JE, Freer JH (eds) Sourcebook of bacterial protein toxins. London, Academic Press. 1991: 376-314.
16. Finck-Barbançon V, Duportail G, Meunier O, Colin DA. Pore formation by a two-component leukocidin from Staphylococcus aureus within the membrane of human polymorphonuclear leukocytes. Biochim Biophys Acta 1993; 1182: 275-282.
17. Colin DA, Mazurier I, Sire S, Finck-Barbancon V. Interaction of the two components of leukocidin from Staphylococcus aureus with human polymorphonuclear leukocyte membranes: sequential binding and subsequent activation. Infect Immun 1994; 62: 3184-3188.
18. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-376.
19. König W, Schönfeld W, Raulf M et al. The neutrophil and leukotrienes: role in health and disease. Eicosanoids 1990; 3: 1-22.
20. Brom J, König W. Cytokine-induced (interleukin-3, -6, and -8 and tumour necrosis factor-β) activation and deactivation of human neutrophils. Immunology 1992; 75: 281-285.
21. Baggiolini M. Neutrophil activation and the role of interleukin-8 and related cytokines. Int Arch Allergy Immunol 1992; 99 196-199.